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Abstract
The effects of the two cannabinomimetic drugs (3)-2-(6a,7,10,10a-tetrahydro-6,6,9-trimethyl-1-hydroxy-6H-dibenzo[b,d]-
pyranyl-2-(hexyl)-1,3-dithiolane (AMG-3) and its pharmacologically less active 1-methoxy analogue (AMG-18) on the
thermotropic and structural properties of dipalmitoyl-sn-glycero-3-phosphorylcholine (DPPC) liposomes have been studied
by X-ray diffraction and differential scanning calorimetry (DSC). DSC data revealed that the incorporation of the drugs
affect differently the thermotropic properties of DPPC. The presence of the more active drug distinctly broadened and
attenuated both the pretransition and main phase transition of DPPC bilayers, while the inactive analogue had only minor
effects. Small and wide angle X-ray diffraction data showed that the two cannabinoids have different effects on the lipid
phase structures and on the hydrocarbon chain packing. The pharmacologically active analogue, AMG-3, was found to
efficiently fluidize domains of the lipids in the LLP gel phase, and to perturb the regular multibilayer lattice. In the liquid
crystalline LK phase, AMG-3 was also found to cause irregularities in packing, suggesting that the drug induces local
curvature. At the same concentration, the inactive AMG-18 had only minor structural effects on the lipids. At about 10-fold
or higher concentrations, AMG-18 was found to produce similar but still less pronounced effects in comparison to those
observed by AMG-3. The dose-dependent, different thermotropic and structural effects by the two cannabinoid analogues
suggest that these may be related to their biological activity. ß 2001 Elsevier Science B.V. All rights reserved.
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1. Introduction
The pharmacological activity of cannabinoids is
believed to be controlled by two cannabinoid recep-
tors (CB1 and CB2) [1,2]. However, certain experi-
mental observations suggest that some physiological
e¡ects of cannabinoids can be attributed to their
structural e¡ects on cellular membranes [3,4]. In par-
ticular, cannabinoids were found to produce bio-
chemical changes in a variety of membrane prepara-
tions, to a¡ect membrane-related function, and to
exert non-receptor-mediated e¡ects on membrane-
bound enzymes [5,6].
Cannabinoids are lipophilic molecules and may
¢rst interact with the lipid microenvironment that
surrounds the membrane-associated enzymes [7,8].
These cannabinoid-phospholipid interactions trigger
changes in the functions of a number of these pro-
teins and thus alter a variety of physiological func-
tions. A mechanism of action that involves cannabi-
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noid-phospholipid interactions has been suggested by
the results of di¡erent physical methods [9^11]. It
was argued in the literature that the possibility exists
also for cannabinoids to interact ¢rst with phospho-
lipids and then to di¡use to reach their speci¢c re-
ceptor [12,13].
In an e¡ort to obtain more detailed information
on the regiochemical and stereochemical require-
ments for productive binding on the active site within
a speci¢c class of cannabinomimetic agents, we have
sought to develop novel ligands possessing high af-
¢nity and selectivity for the cannabinoid receptors.
Structure-activity relationship studies of classical
cannabinoids have established that the alkyl chain
at the C-3 position is an essential pharmacophore
for cannabinoid activity. Our interest in exploring
the role of side chain conformation on the activity
of cannabinoids led us to design and synthesize ana-
logues in which the side chain is conformationally
more de¢ned by adding substitution on the C-1P po-
sition.
Among the analogues synthesized, compound
2-[6a,7,10,10a-tetrahydro-6,6,9-trimethyl-1-hydroxy-
6H-dibenzo[b,d]pyranyl]-2-(hexyl)-1,3-dithiolane
(AMG-3) (Fig. 1) was found to be a potent canna-
binomimetic probe, with very high a⁄nity to both
cannabinoid receptors (Ki values of 0.32 and
0.52 nM for CB1 and CB2 receptors, respectively)
[14]. The very high a⁄nity of this analogue was at-
tributed to two factors. First, its increased hydropho-
bicity at the benzylic side chain carbon may ¢t to a
corresponding hydrophobic site of a receptor. Sec-
ond, the side chain pharmacophore is conformation-
ally more de¢ned than the prototype cannabinoid
(3)-v8-THC. These structural characteristics may
promote its proper integration into lipid bilayers
and facilitate its interaction with the receptor when
di¡using towards the active site, or may result in
more favourable interactions with the phospholipid
environment surrounding the enzymes or receptors.
In parallel, its methoxy analogue (AMG-18) was also
synthesized. This analogue lacks the phenolic hy-
droxyl group and possesses less biological activity.
In the present study X-ray di¡raction and di¡er-
ential scanning calorimetry (DSC) techniques were
used to determine the e¡ects of the interactions of
AMG-3 and AMG-18 with the lipid bilayer structure
in order to determine whether their di¡erences in
biological activity could be related to changes in
the physical properties of membrane lipids. The com-
pounds in this study have similarities to the (3)-v8-
THC and (3)-Me-v8-THC cannabinoid pair, which
has previously been studied using various biophysical
techniques. Interestingly, these previous studies with
the cannabinoid pair (3)-v8-THC and (3)-Me-v8-
THC have shown di¡erential e¡ects [15,16]. These
promising results led us to apply small and wide
angle X-ray di¡raction (SWAX) with fully hydrated
phospholipid multibilayers to study the e¡ects of
AMG-3 and AMG-18. To our knowledge this is
the ¢rst study in which SWAX is used to detect dif-
ferential e¡ects of drugs in the membrane bilayers.
2. Materials and methods
2.1. Synthesis of AMG-3 and AMG-18
The synthesis of the two cannabinoids was
achieved according to published methods [14].
2.1.1. Structure identi¢cation of (3)-2-(6a,7,10,10a-
Tetrahydro-6,6,9-trimethyl-1-hydroxy-6H-
dibenzo[b,d]pyrany1)-2-hexyl-1,3-dithiolane
(AMG-3)
1H NMR (300 MHz, CDCl3) d 6.8 (d, J = 1.98 Hz,
1H, H4), 6.6 (d, J = 1.98 Hz, 1H, H2), 5.45 (bs, 1H,
H8), 4.75 (s, 1H, OH), 3.4^3.2 (m, 4H, -S(CH2)2S-),
3.20 (m, 1H, H10c), 2.7 (br s, 1H, H10K), 2.3 (m, 2H,
2P CH2), 2.15 (m, 1H, H7), 2.05^1.83 (m, 3H, H6K,
H7, H10L;), 1.7 (s, 3H), 1.4 (s, 3H), 1.25 (br s, 8H,
Fig. 1. Chemical structures of 2-[6a,7,10,10a-tetrahydro-6,6,9-
trimethyl-6H-dibenzo[b,d]pyran-1-ol]-2-[hexyl]-1,3-dithiolane
(AMG-3) and its methoxy analogue (AMG-18).
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-CH2-), 1.1 (s, 3H), 0.85 (t, J = 7 Hz, 3H). Anal.
(C25H36O2S2) C, H.
2.1.2. Structure identi¢cation of (3)-2-(6a,7,10,10a-
Tetrahydro-6,6,9-trimethyl-1-methoxy-6H-
dibenzo[b,d]pyrany1)-2-hexyl-1,3-dithiolane
(AMG-18)
1H NMR (300 MHz, CDCl3) d 6.78 (d, J = 1.88
Hz, 1H, H4), 6.7 (d, J = 1.88 Hz, 1H, H2), 5.40 (bs,
1H, H8), 3.80 (s, 3H, OCH3), 3.33^3.26 (m, 4H,
-S(CH2)2S-), 3.20 (m, 1H, H10K), 2.65 (br s, 1H,
H10K), 2.3 (m, 2H, 2P CH2), 2.10 (m, 1H, H7),
2.05^1.83 (m, 3H, H6K, H7, H10L;), 1.7 (s, 3H), 1.4
(s, 3H), 1.25 (br s, 8H, -CH2-), 1.1 (s, 3H), 0.75
(t, J = 7 Hz, 3H). Anal. (C26H38O2S2) C, H.
2.2. Materials used in biophysical studies
1,2-Dipalmitoyl-sn-glycero-3-phosphorylcholine
(DPPC, purity s 99%) was obtained from Avanti
Polar Lipids (AL, USA) and used without further
puri¢cation. The sample preparation procedure was
identical for DSC and X-ray di¡raction. Appropriate
amounts of phospholipid with or without cannabi-
noid were dissolved in chloroform/methanol (2:1,
spectroscopic grade). The solvent was then evapo-
rated by passing a stream of O2-free nitrogen over
the solution, and the residue was placed under vac-
uum (0.1 mmHg) for 12 h. For X-ray or DSC mea-
surements, this dry residue was dispersed in appro-
priate amounts of bidistilled water to a concentration
of 50% (w/w) by vortexing at 45‡C, i.e. above the
chain-melting transition of DPPC. Before tempera-
ture scan experiments, the samples were equilibrated
at 4‡C for 4 h.
2.3. X-Ray di¡raction
Small and wide angle X-ray experiments were per-
formed using an integrated SWAX system (Hecus M.
Braun-Graz X-ray Systems, Graz, Austria), Kratky
line collimation, equipped with a linear position-sen-
sitive detector, a semitransparent beam stop for on-
line measurement of the primary beam, and an au-
tomatic temperature/time programmer and data col-
lection unit. The camera was operated at a rotating
anode generator (RU-200B; Rigaku Denki, Japan),
at 40 kV/70 mA, with Ni-¢ltered Cu-KK radiation
(wavelength 0.154 nm). Measurements were taken
in the range between 4 and 45‡C, with measuring
times of 1000 s per temperature setting, and 300 s
waiting time at each temperature before measure-
ment. All scattering curves were background cor-
rected and normalized to integral primary beam in-
tensity [17].
2.4. DSC
After adding distilled water to the dry lipid/drug
mixture (50% w/w), a portion of the sample (approx.
5 mg) was sealed in a stainless steel capsule. Thermo-
grams were obtained on a Perkin-Elmer DSC-7 in-
strument. All samples were scanned at least twice
until identical thermograms were obtained using a
scanning rate of 2.5‡C/min. The temperature scale
Fig. 2. Normalized di¡erential scanning calorimetry scans of
fully hydrated bilayers of DPPC with or without AMG-3 or
AMG-18. The labelled scans with x = 0.01 (1 mol%) and x = 0.1
(10 mol%) refer to the corresponding added concentrations of
AMG-18 or AMG-3.
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of the calorimeter was calibrated using fully hydrated
DPPC and indium as standard samples. We found
that the thermograms from samples stored at freezer
temperatures (315‡C) for several days were identical
to those run immediately after sample preparation.
3. Results
3.1. Di¡erential scanning calorimetry
The e¡ects of the two cannabinoids on the thermal
behaviour of DPPC [18] in aqueous dispersion are
shown in Fig. 2, and the relevant calorimetric param-
eters are summarized in Table 1. The DPPC bilayer
exists in the gel phase (LLP) for temperatures lower
than 33‡C, and in the liquid crystalline phase for
temperatures higher than 42‡C (LKP). In between
33 and 42‡C the phospholipid bilayer exists in PLP
or ripple phase. The obtained DSC scan of fully
hydrated DPPC multibilayers shows a pretransition
centred at 35‡C and a peak maximum at 41.2‡C. The
main phase transition is accompanied by several
structural changes in the lipid molecules as well as
systematic alterations in the bilayer geometry, but
the most prominent feature is the trans-gauche iso-
merization taking place in the acyl chain conforma-
tion. The average number of gauche conformers in-
dicates the e¡ective £uidity, which depends not only
on the temperature, but also on perturbations due to
the presence of a drug molecule intercalating between
the lipids.
While the control DPPC sample showed the well
known features of pre- and main transitions, the
presence of the cannabinoids had signi¢cant e¡ects
on both mesomorphic phase transitions of DPPC,
however, with di¡erent calorimetric features for the
two compounds. The presence of 1 mol% inactive
analogue AMG-18 has only minor e¡ects on the
transition thermograms. Using the same concentra-
tion of the active analogue AMG-3 induces a strong
broadening and decrease in temperature of the pre-
transition. The main transition is also broadened and
the peak temperature is decreased by about 2‡C. A
shoulder is observed (labelled in Fig. 2) at the high
temperature tail of the transition suggesting phase
separation. The integral transition enthalpy is de-
creased by about 25% relative to the control DPPC
system. At 10 mol%, the presence of the inactive
analogue causes broadening of the transition thermo-
grams. Again, at the same concentration, AMG-3
Table 1
Pretransition and transition temperatures (Tc), and enthalpy
(vH) of the studied preparations
Sample Tc (‡C) vH (cal/g)
DPPC 35.2, 41.2 1.6, 12.5
DPPC/(x = 0.01) AMG-18 35.6, 42.6 1.1, 10.7
DPPC/(x = 0.01) AMG-3 30.7, 39.1 0.3, 9.4
DPPC/(x = 0.1) AMG-18 33.4, 42.2 0.7, 10.1
DPPC/(x = 0.1) AMG-3 ^, 37.3a 7.8
The ¢rst values in each column correspond to the pretransition,
whereas the second values correspond to the main phase transi-
tion.
aRepresents the highest peak of the DSC scan.
Fig. 3. Small angle X-ray di¡raction patterns of (a) DPPC;
(b) DPPC+1 mol% AMG-3 and (c) DPPC and 1 mol% AMG-
18 at 20, 33 and 45‡C.
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exerted more signi¢cant broadening of the phase
transition in DPPC multibilayers. Three di¡erent
maxima are clearly visible and labelled in the same
¢gure.
3.2. X-Ray di¡raction
3.2.1. Small angle X-ray di¡raction
The small angle di¡raction patterns for DPPC bi-
layers without and with 1 mol% cannabinoid are
shown in Fig. 3 for the three representative temper-
atures 20‡C, 33‡C and 45‡C which cover all meso-
morphic states of the phospholipid bilayers.
DPPC bilayers in the gel phase show four distinct
sharp di¡raction orders indicating a high stacking
regularity of the membrane phospholipids. At tem-
peratures between the pretransition and main transi-
tion the structure is formed by corrugated bilayers
with a periodic ripple and hexagonal chain packing.
This is seen as a broadening of the re£ections. At the
liquid crystalline phase (LKP), a sharpening of the
peaks and an increase in intensity as well as di¡use
scattering towards zero angle is observed [19]. At the
gel and liquid crystalline phases 1 mol% AMG-18
causes only marginal changes in the di¡raction pat-
tern of DPPC. In the pretransition state the presence
of AMG-18 causes a broadening e¡ect on the dif-
fraction peaks. The presence of active cannabinoid
AMG-3 at 1 mol% and at the gel phase causes
broadening of the di¡raction peaks and the pattern
has strong similarities to the PLP ‘ripple phase’ or at
the pretransition state shown in the di¡raction pat-
terns at 33‡C of DPPC bilayers alone. These results
indicate that the planar multibilayer gel structure be-
comes disordered by the presence of AMG-3. A clear
sign for a periodic corrugation, however, cannot be
found; it appears that the lattice correlation between
the bilayers is lost through non-correlated domains
of local curvature induced by AMG-3. The broad-
ening e¡ect of AMG-3 both in pretransition and liq-
uid crystalline phases is more pronounced than that
of DPPC bilayers and bilayers containing AMG-18.
The same trend is emerging using higher concen-
trations of cannabinoids (data not shown). For ex-
ample at concentrations of 10 mol% and 20 mol%
the two cannabinoids enhance their e¡ects with the
active one still to exert more signi¢cant e¡ects.
3.2.2. d-Spacing versus temperature measurements
The total period repeat distances (d-spacing) mea-
sured for the three preparations at the concentrations
of 1 mol% and 10 mol% are shown in Fig. 4. At gel
phase and using 1 mol% concentration of drug only
the active one causes an increase of d-spacing. The
Fig. 4. Lamellar repeat d-spacing versus temperature of (a) DPPC (b) ; (b) DPPC+1 mol% AMG-3 (9F9) ; (c) DPPC+1 mol%
AMG-18 (W W WRW W W) (d) DPPC+10 mol% AMG-3 (^ W ^F^ W ^); (e) DPPC+10 mol% AMG-18 (9R9).
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pretransition is seen by the shift of the dominant
small angle peak to larger spacings (i.e. smaller an-
gles), by about the same amount as in the reference
DPPC system at temperatures between 33 and 35‡C.
The appearance of distinct shoulders of the domi-
nant small angle peak towards larger angles indicates
that a rippled PLP-like structure also prevails in the
presence of AMG-3. Therefore, the PLP structure ap-
pears to be the one which is least a¡ected by AMG-
3.
The d-spacing versus temperature pro¢le of DPPC
bilayers containing 1 mol% AMG-3 is distinctly
broader than that of DPPC and DPPC+1 mol%
AMG-18 preparations, indicating an increase in bi-
layer stacking disorder caused by the active cannabi-
noid. This broadening is in agreement with DSC re-
sults. AMG-18 exerts much weaker e¡ects on the
bilayer stacking order and dimensions. The only no-
ticeable e¡ect is its cause of the lowering of the pre-
transition by about 2‡C. The temperature depen-
dence of the d-spacing at 10 mol% is also shown in
Fig. 4. The results demonstrate that the presence of
the active analogue in the DPPC bilayer phase still
causes more broadening in the phase transition tem-
perature than the inactive one, in agreement with
DSC data. The intensity and d-spacing with the ac-
tive AMG-3 di¡er signi¢cantly from those of DPPC,
but to a lesser degree from those of the inactive ana-
logue AMG-18.
3.2.3. Wide angle X-ray di¡raction
Fig. 5 shows the wide angle X-ray di¡raction pat-
terns of DPPC bilayers without and with 1 mol% of
cannabinoid. The wide angle pattern of DPPC bi-
layers at the gel phase where there is a tilted hydro-
carbon chain packing, belonging to the orthorhom-
bic subcell symmetry [20], is re£ected by a prominent
(2/0) peak around 4.22 Aî (s = 1/d = 0.24 Aî 31) and a
shoulder at 4.12 Aî (1/1). Above the pretransition,
there is a merge of the two peaks into one symmetric
peak around 4.21 Aî and the intensity is signi¢cantly
reduced, suggesting the coexistence of £uid, disor-
dered domains with ordered, hexagonally packed hy-
drocarbon chains, in agreement with NMR and re-
cent X-ray data [17^20]. At the liquid crystalline
phase a total disappearance of sharp wide angle
peaks is observed. The wide angle patterns of
DPPC bilayers containing 1 mol% AMG-18 resemble
those of DPPC bilayers. Thus, the 4.22/4.11 peaks/
shoulder pattern changes into a 4.21 Aî symmetrical
peak. The wide angle di¡raction patterns of bilayers
containing 1 mol% active analogue show one weak
peak around 4.21 Aî already from 20‡C. This indi-
cates a substantial loss in chain packing order. The
peak asymmetry resembles that of the LLP pattern,
and it is therefore suggested that this relates to a
reduced population of ordered, tilted chain domains
within an increased proportion of disordered chains.
When higher concentrations are used the active ana-
logue still has stronger e¡ects.
4. Discussion
The present investigation on cannabinoid drug-lip-
Fig. 5. Wide angle X-ray di¡raction patterns of (a) DPPC;
(b) DPPC+1 mol% AMG-3 at 20, 33 and 45‡C.
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id membrane interaction was aimed at the following
question: do drugs with di¡erent biological activity
perturb lipid bilayers in the same manner? A positive
answer to this question may substantially enhance
our understanding of the molecular mechanism of
drug action.
The two cannabinoid analogues investigated in
this study have only a minor structural di¡erence.
AMG-3 possesses a phenolic hydroxyl group while
in AMG-18 this is replaced by a methoxy group.
Such a small structural di¡erence in relatively com-
plex organic compounds could be expected to be
distinguishable only by a speci¢c receptor protein.
However, the present results show detectable di¡er-
ences in their interactions with DPPC bilayer mem-
branes. There appears to be a complementary role
for cannabinoid-lipid interaction in speci¢c receptor
recognition. In fact, it is argued in the literature that
lipophilic drugs ¢rst are incorporated into the lipid
matrix and then di¡use laterally towards the receptor
site. Therefore, the topography and orientation of a
drug molecule in the membrane bilayer may govern
its approach towards the receptor site [12,13]. Con-
sequently, both topography and orientation of drug
molecules in membrane bilayers result from the phys-
icochemical drug-membrane interactions.
It is convenient for the present discussion to ¢rst
treat preparations that contain 1 mol% drug since
these may be more relevant pharmacologically. The
use of preparations that contain 10 mol% drug serves
to describe the common trends of action by both
analogues. The most noticeable e¡ect of the active
analogue, AMG-3, is £uidization, or disordering, of
the hydrocarbon chains in the gel phase. This is ac-
companied by a disjoining and progressive random-
ization of the bilayer lea£ets in the multilamellar
stacks. The observation of a larger average repeat
spacing, by about 2^9 Aî , in the presence of AMG-
3, can be taken as an indication for an increased
thickness of the interbilayer water space which can
be plausibly explained by the steric repulsion of bi-
layers with enhanced random, local curvature. Inter-
estingly, using 1 mol% of AMG-18, these e¡ects are
practically negligible, but at 10 mol% they are quite
visible.
Nothing is presently known on the arrangement of
either cannabinoid analogue in the lipid bilayer
membrane. We can only speculate that AMG-3 par-
titions favourably into the hydrocarbon chain region,
even in the LLP phase, which it partially £uidizes ac-
cording to the present results. The bilayer appears to
consist of £uid, AMG-containing domains, coexist-
ing with domains of ordered LLP phase. One possible
consequence is that the elastic deformability of the
membranes, and hence also the dynamic undulation
[20,21], increase to lead to enhanced disorder. This
could possibly explain the e¡ects observed in the LLP
gel phase, but it is not su⁄cient to interpret the dis-
ordering in the liquid crystalline LKP phase, where the
chains are already £uid. We propose that AMG-3
causes local, positive curvature formation at the
site of its intercalation into one half of a bilayer.
Such local and uncorrelated ‘bumps’, which are not
to be confused with dynamic undulation, could ac-
count for the increase in lamellar packing disorder.
The fact that the ‘ripple’ phase, PLP, is least a¡ected
by the interaction with AMG-3 could be interpreted
by the notion that there the drug inserts into the
already curved ridges of the sawtooth structure.
The intercalation of the active drug molecule into
membrane bilayers leads to a local expansion which
can only be accommodated if the bilayer curves at
this site, which in turn leads to a local £uidization of
the annulus of lipids around the site of interaction.
The phenolic hydroxyl group of AMG-3 serves as an
anchor within the polar head group region of the
lipids. This molecular feature is lacking with AMG-
18 and this may explain its lesser e¡ects on the phos-
pholipid bilayers. It remains to be established by
future studies to what extent and how this molecule
is inserting into the bilayer. At higher concentrations
the e¡ects of AMG-3 and AMG-18 become closely
similar. This indicates that their e¡ects are not pro-
gressing in a linear fashion and approach saturation
at very high concentrations.
In terms of methodology the present study shows
that X-ray small and wide angle di¡raction is very
sensitive to structural alterations of lipid bilayers
upon incorporation of an additive. In addition, since
SWAX is a fast technique, these results should stim-
ulate further investigations by the researchers work-
ing in the ¢eld of drug-membrane interactions and
investigating problems related to biology and medic-
inal chemistry.
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